T. Ikeo

发表

T-1032, a novel specific phosphodiesterase type 5 inhibitor, increases venous compliance in anesthetized rats.

H. Inoue, K. Kikkawa, K. Yano, 2001, European journal of pharmacology.

Effects of denopamine (TA-064), a new positive inotropic agent, on myocardial oxygen consumption and left ventricular dimension in anesthetized dogs.

T. Nagao, T. Ikeo, 1985, Japanese journal of pharmacology.

Inhibitory effects of TA-993 and its metabolite MB3 on platelet activation induced by collagen and U-46619 in human platelets.

M. Takagi, M. Katoh, T. Karasawa, 2001, Biological & pharmaceutical bulletin.

Pharmacological profile of T-1032, a novel specific phosphodiesterase type 5 inhibitor, in isolated rat aorta and rabbit corpus cavernosum.

H. Inoue, M. Takagi, K. Kikkawa, 2001, European journal of pharmacology.

Acute and chronic effects of T-1032, a novel selective phosphodiesterase type 5 inhibitor, on monocrotaline-induced pulmonary hypertension in rats.

H. Inoue, M. Takagi, K. Kikkawa, 2002, Biological & pharmaceutical bulletin.

Antiplatelet mechanisms of TA-993 and its metabolite MB3 in ADP-induced platelet aggregation.

M. Takagi, H. Narita, M. Katoh, 2000, European journal of pharmacology.

Cardiovascular effects of a new positive inotropic agent, (-)-(R)-1-(p-hydroxyphenyl)-2-[(3,4-dimethoxyphenethyl)amino]-ethanol (TA-064) in the anesthetized dog and isolated guinea pig heart.

T. Nagao, H. Nakajima, T. Ikeo, 1984, Japanese journal of pharmacology.

T-1032, a novel phosphodiesterase type 5 inhibitor, increases the survival of cardiomyopathic hamsters.

H. Inoue, M. Takagi, K. Kikkawa, 2002, European journal of pharmacology.

Influence of calcium ions on responses to diltiazem in coronary arteries.

T. Nagao, T. Ikeo, M. Sato, 1977, Japanese journal of pharmacology.

1-Arylnaphthalene lignan: a novel scaffold for type 5 phosphodiesterase inhibitor.

J. Kotera, T. Ukita, Y. Nakamura, 1999, Journal of medicinal chemistry.

Cardiovascular effects and plasma levels of denopamine (TA-064), a new positive inotropic agent, in chronically instrumented dogs.

T. Nagao, H. Nakajima, T. Suzuki, 1985, Japanese journal of pharmacology.

Potentiation of penile tumescence by T-1032, a new potent and specific phosphodiesterase type V inhibitor, in dogs.

H. Inoue, K. Kikkawa, T. Ikeo, 2000, The Journal of pharmacology and experimental therapeutics.

[Interactions by diltiazem (3). Mechanism of enhancement of propranolol absorption by diltiazem].

K. Kohno, T. Ikeo, A. Etoh, 1983, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Cardiovascular effects of the new positive inotropic agent denopamine with special reference to species difference and the effect on failing heart.

T. Nagao, H. Nakajima, T. Ikeo, 1986, Arzneimittel-Forschung.

Beta 1-adrenergic selectivity of the new cardiotonic agent denopamine in its stimulating effects on adenylate cyclase.

T. Nagao, S. Takeyama, T. Ikeo, 1987, Biochemical pharmacology.

In vivo evaluation of left ventricular function in aged SHR by volume loading and the positive inotropic effect of denopamine.

T. Nagao, T. Ikeo, 1986, Japanese journal of pharmacology.

Effect of a new anticholinergic agent (SA-504) on motility of the gastrointestinal tract and the urinary bladder in cats.

S. Harigaya, H. Nakajima, H. Tamaki, 1973, Japanese journal of pharmacology.

[Hypotensive effects of diltiazem in DOCA/saline hypertensive rats (author's transl)].

K. Ikezawa, T. Ikeo, M. Sato, 1979, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.